Enprostil

Jump to: navigation, search
Enprostil.png
Enprostil
Systematic (IUPAC) name
Methyl 7-[(1R,2R,3R)- 3-hydroxy-2-[(1E,3R)- 3-hydroxy-4-phenoxy-1-butenyl]-5-oxocyclopentyl]- 4,5-heptadienoate
Identifiers
CAS number 73121-56-9
ATC code A02BB02
PubChem 51744
Chemical data
Formula C23H28O6 
Mol. mass 400.46 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for Enprostil

Articles

Most recent articles on Enprostil

Most cited articles on Enprostil

Review articles on Enprostil

Articles on Enprostil in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Enprostil

Images of Enprostil

Photos of Enprostil

Podcasts & MP3s on Enprostil

Videos on Enprostil

Evidence Based Medicine

Cochrane Collaboration on Enprostil

Bandolier on Enprostil

TRIP on Enprostil

Clinical Trials

Ongoing Trials on Enprostil at Clinical Trials.gov

Trial results on Enprostil

Clinical Trials on Enprostil at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Enprostil

NICE Guidance on Enprostil

NHS PRODIGY Guidance

FDA on Enprostil

CDC on Enprostil

Books

Books on Enprostil

News

Enprostil in the news

Be alerted to news on Enprostil

News trends on Enprostil

Commentary

Blogs on Enprostil

Definitions

Definitions of Enprostil

Patient Resources / Community

Patient resources on Enprostil

Discussion groups on Enprostil

Patient Handouts on Enprostil

Directions to Hospitals Treating Enprostil

Risk calculators and risk factors for Enprostil

Healthcare Provider Resources

Symptoms of Enprostil

Causes & Risk Factors for Enprostil

Diagnostic studies for Enprostil

Treatment of Enprostil

Continuing Medical Education (CME)

CME Programs on Enprostil

International

Enprostil en Espanol

Enprostil en Francais

Business

Enprostil in the Marketplace

Patents on Enprostil

Experimental / Informatics

List of terms related to Enprostil


Enprostil is a synthetic prostaglandin designed to resemble dinoprostone.

It is classified by the World Health Organization under "A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease."

External links

  • Toshina K, Hirata I, Maemura K, Sasaki S, Murano M, Nitta M, Yamauchi H, Nishikawa T, Hamamoto N, Katsu K (2000). "Enprostil, a prostaglandin-E(2) analogue, inhibits interleukin-8 production of human colonic epithelial cell lines.". Scand J Immunol. 52 (6): 570–5. PMID 11119262. 
  • Tari A, Hamada M, Kamiyasu T, Sumii K, Haruma K, Inoue M, Kishimoto S, Kajiyama G, Walsh J (1997). "Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.". Dig Dis Sci. 42 (8): 1741–6. PMID 9286243. 
  • Ching C, Lam S (1995). "A comparison of two prostaglandin analogues (enprostil vs misoprostol) in the treatment of acute duodenal ulcer disease.". J Gastroenterol. 30 (5): 607–14. PMID 8574332. 



Linked-in.jpg